Real World Long-term Assessment of The Efficacy of Tocilizumab in Patients with COVID-19: Results From A Large De-identified Multicenter Electronic Health Record Dataset in the United States

Real World Long-term Assessment of The Efficacy of Tocilizumab in Patients with COVID-19: Results From A Large De-identified Multicenter Electronic Health Record Dataset in the United States

Background: Studies have shown conflicting results on the efficacy of tocilizumab (TCZ) for patients with COVID-19, with many confounders of clinical status and limited duration of the observation. Here, we evaluate the real-world long-term efficacy of TCZ in COVID-19 patients. Methods: We conducted...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Masayuki Nigo, Laila Rasmy, Sarah B. May, Aishwarya Rao, Sam Karimaghaei, Bijun Sai Kannadath, Alejandro De la Hoz, Cesar A. Arias, Liang Li, Degui Zhi
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Tocilizumab
COVID-19
De-identified Database
Infectious and parasitic diseases
RC109-216
Acceso en línea:https://doaj.org/article/b999958492c148f98c3cedd11fa10a1c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/b999958492c148f98c3cedd11fa10a1c

Ejemplares similares